BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2587007)

  • 1. Value of aceto-orcein squash preparations in the cytogenetic study of solid tumours.
    Atkin NB; Baker MC
    Oncology; 1989; 46(6):405-7. PubMed ID: 2587007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A squamous cell bladder carcinoma with karyotypic abnormalities reminiscent of transitional cell carcinoma.
    Lundgren R; Elfving P; Heim S; Kristoffersson U; Mandahl N; Mitelman F
    J Urol; 1989 Aug; 142(2 Pt 1):374-6. PubMed ID: 2746756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Karyotype analysis of four solid gynecologic tumors.
    Kusyk CJ; Turpening EL; Edwards CL; Wharton JT; Copeland LJ
    Gynecol Oncol; 1982 Dec; 14(3):324-38. PubMed ID: 6961093
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytogenetic aberrations in bladder carcinoma.
    Roy JB; Dagg K; Bottomley R
    Mil Med; 1984 Nov; 149(11):622-3. PubMed ID: 6438554
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chromosomal analysis of primary superficial tumors of the bladder].
    Martorana G; Giberti C; de Ferrari M; Ottaggio L; Giuliani L
    J Urol (Paris); 1983; 89(7):489-92. PubMed ID: 6655279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial cytogenetic analysis in a patient with pseudodiploid bladder cancer.
    Kovacs G
    J Cancer Res Clin Oncol; 1985; 110(3):249-51. PubMed ID: 4077924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytogenetic aspects of uterine carcinomas].
    De Cecco L; Rugiati S; Sbernini R
    Quad Clin Ostet Ginecol; 1966 Sep; 21(9):562-73. PubMed ID: 5993024
    [No Abstract]   [Full Text] [Related]  

  • 8. Chromosomal and cell kinetic pattern in human transitional cell bladder carcinoma.
    Silvestrini R; Costa A; Lavezzi AM; Matturri L
    Basic Appl Histochem; 1987; 31(2):191-7. PubMed ID: 3632564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic analysis of urologic malignancies: study of tumor colony forming cells and premature chromosome condensation.
    Trent JM; Stanisic T; Olson S
    J Urol; 1984 Jan; 131(1):146-51. PubMed ID: 6690740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment by M-FISH of karyotypic complexity and cytogenetic evolution in bladder cancer in vitro.
    Ratliff TL
    J Urol; 2005 Nov; 174(5):2065. PubMed ID: 16217396
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cytogenetic analysis of transitional cell carcinoma of the bladder, stage B (pT2-3a/pN0)].
    Angulo JC; López JI; Sanchez-Chapado M
    Actas Urol Esp; 1994 Jun; 18(6):651-5. PubMed ID: 7942216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms.
    Mertens F; Johansson B; Höglund M; Mitelman F
    Cancer Res; 1997 Jul; 57(13):2765-80. PubMed ID: 9205089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetics of bladder cancer: a cytogeneticist's perspective.
    Wolff DJ
    Cytogenet Genome Res; 2007; 118(2-4):177-81. PubMed ID: 18000368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic studies of human endometrial carcinomas by means of tissue culture.
    Kuramoto H; Hamano M
    Acta Cytol; 1977; 21(4):559-65. PubMed ID: 269609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
    Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
    Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo assessment of urinary bladder malignancy.
    Karr JP; Pontes JE; Murphy GP; Gibas Z; Sandberg AA
    Prog Clin Biol Res; 1984; 162A():331-46. PubMed ID: 6592614
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytogenetic monoclonality in multifocal uroepithelial carcinomas: evidence of intraluminal tumour seeding.
    Fadl-Elmula I; Gorunova L; Mandahl N; Elfving P; Lundgren R; Mitelman F; Heim S
    Br J Cancer; 1999 Sep; 81(1):6-12. PubMed ID: 10487605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
    Osman I; Scher HI; Zhang ZF; Pellicer I; Hamza R; Eissa S; Khaled H; Cordon-Cardo C
    Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities detected in metaphase chromosomes in bladder carcinoma: prognostic value and comparison with histopathological factors.
    Oosterhuis JW; Smeets AW; Janssen-Heijnen ML; Schapers RF; Pauwels RP; Newling DW
    Virchows Arch; 2002 Aug; 441(2):187-93. PubMed ID: 12189510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal aberrations in Cis and Ta bilharzial bladder cancer: a theory of pathogenesis.
    Khaled HM; Aly MS; Mokhtar N
    Urol Oncol; 2004; 22(6):443-7. PubMed ID: 15610858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.